NCT03774511

Brief Summary

background: Obesity, diabetes mellitus type II and fatty liver disease combining with low levels of physical activity are prominent health risks for mortality and morbidity. More than 1/3 of the current population is suffering from obesity with a significant proportion to medical complications which can negatively influence their quality of life. These complications comprise alterations of the metabolism of glucose and fat, insulin resistance and diabetes mellitus. Objectives The purpose of this study was to compare between high intensity interval exercise and moderate intensity continuous on diabetic obese patients with NAFLD. Methods: forty-seven diabetic obese individuals with NAFLD were enrolled in this study. The individuals were randomly divided into 16 in HII group, 15 in MIC group, and 16 in the controls. HII group received HII exercise, MIC group received 8-week MIC exercise while the control group did not receive any exercise intervention. IHTG and visceral lipids were assessed pre- and post-intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable diabetes

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 9, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 12, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 13, 2018

Completed
Last Updated

June 26, 2020

Status Verified

June 1, 2020

Enrollment Period

1.1 years

First QC Date

December 12, 2018

Last Update Submit

June 24, 2020

Conditions

Outcome Measures

Primary Outcomes (8)

  • Intrahepatic triglyceride (%)

    Assessment in percentage (%) using MRI with a 3T scanner (General electric, WI) through imaging of chemical shift. Each patient was assessed for imaging in the supine position using the body coil. The patient was instructed to make a single breath hold during imaging, the liver was imaged 3 separate images slice pairs. IHTG proportionate to water was estimated as 100 × (signal amplitude of TG)/(signal amplitude of water).

    8 weeks

  • Total cholesterol

    Total cholesterol, (mg/dL)

    8 weeks

  • Triglycerides

    Triglycerides, (mg/dL)

    8 weeks

  • High-density lipoproteins (HDLs)

    High-density lipoproteins (HDLs), (mg/dL)

    8 weeks

  • Low-density lipoproteins (LDLs)

    Low-density lipoproteins (LDLs), (mg/dL)

    8 weeks

  • Alanine-transaminase (ALT)

    Alanine-transaminase (ALT), (IU/L)

    8 weeks

  • Hemoglobin A1c (HbA1c)

    Hemoglobin A1c (HbA1c), (%)

    8 weeks

  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

    It was assessed through Blood Code Calculation: HOMA-IR = Insulin (mU/L) х Glucose (mg/dL).

    8 weeks

Secondary Outcomes (4)

  • Weight

    8 weeks

  • Height

    8 weeks

  • Body mass index (BMI)

    8 weeks

  • Visceral adipose fat

    8 weeks

Study Arms (3)

Study group 1

ACTIVE COMPARATOR

High Intensity Interval Excercise

Other: High-Intensity Interval Exercise & Moderate Intensity Interval Exercise

Study group 2

ACTIVE COMPARATOR

Moderate Intensity Interval Exercise

Other: High-Intensity Interval Exercise & Moderate Intensity Interval Exercise

Control group

NO INTERVENTION

No Intervention

Interventions

Different Interval intensities Exercise

Also known as: Exercise
Study group 1Study group 2

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of NAFLD, type II DM, and obesity.
  • Body mass index (BMI) ≥30 kg/m2.
  • Age: 40-60 years
  • No smoking.

You may not qualify if:

  • Severe life limiting illness (cancer, renal failure),
  • Uncontrolled heart disease,
  • Neuromuscular limitations,
  • Orthopedic problems
  • Endocrine disorders that could affect physical exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Sayed Tanatwy

Giza, Egypt

Location

MeSH Terms

Conditions

Diabetes MellitusNon-alcoholic Fatty Liver DiseaseObesityMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesFatty LiverLiver DiseasesDigestive System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Sayed A Tantawy, PhD

    Cairo University, Giza, Egypt

    PRINCIPAL INVESTIGATOR
  • Walid K Abdelbasset, PhD

    Cairo University, Giza, Egypt

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
HII group, each patient in this group were conducted a program of high-intensity aerobic exercise for 8 weeks, three times per week with each exercise session lasting for nearly 40 minutes morning. Each patient was instructed to not eat for 2 hours before the exercise session to avoid exercise induced airway obstruction. MIC group, each patient was received (MIC 3 times/week) for eight weeks, according to following parameters; 5 minutes warm up, followed by 30 minutes of continuous aerobic exercise on a cycle Ergometer with constant intensity at 70 to 75% of peak HR and 5 minutes cool down. Also, these measures were obtained at the beginning and the end of the intervention. Control group only received medical treatment with no exercise intervention
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 12, 2018

First Posted

December 13, 2018

Study Start

July 9, 2017

Primary Completion

August 10, 2018

Study Completion

December 10, 2018

Last Updated

June 26, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations